CBMX financial condition is on the mend from a year ago, and all the good PR's amount to better day's ahead for this beaten up underdog. If you are not a day trader, and think long term, next February can be very rewarding for holders of this stock.
This is headed much higher in the not too distant future.
Cat is out of the bag, horse is out of the barn, time to cover shorts & go long.
I will be adding on any attempt to fill gap.
Sentiment: Strong Buy
I will short the spikes and make profit every single time.
That said, if day trading is not your bag, you are probably on to something nice here. I reckon it is safer than 50% of this overhyped market............
Long weekend to think it over. Maybe more positive news on the way, and another wave of buying..... Or profession sell program. Many people held today, I'm betting higher PPS on the way next week.
She'll break one way or another next week irrespective of news. If there is good news, of which there has been plenty recently, the shorts are toast...this thing has and can double in a day.
there will be many more days with news that produces surges and exit opportunities for those looking for exits but also that there is momentum that will not be beaten by trading manipulation.
I'll be happy if we see $4 in Q1 and after that, could become a 5 year fan.
there has been 1 year of constant good news, there are 5 million shares total...I mean: we have seen this all year...the shareprice will never past $4,50. Not even when somebody takes over the company
Targeted comparative genomic hybridization microarray testing or single nucleotide
polymorphism (SNP) chromosomal microarray analysis is medically necessary in either of the following
Abnormal fetal anatomical findings
Miscarried fetus or stillbirth
Comparative genomic hybridization microarray testing or single nucleotide polymor
chromosomal microarray analysis is medically necessary
in the evaluation of patients with one or more of the following:
Multiple anomalies not specific to a well delineated genetic syndrome and cannot be identified
by a clinical evaluation alone
Sentiment: Strong Buy
This will begin to climb once the camel has filled his tank. That shouldn't take long with this stock.
In short (pun intended) it will come down to "the camel that broke the straw's (short's) back".
Smart shorts understand this and know that heavy shortly is now a thing of the past.
Note To Shorts: "History always repeats itself...except when it doesn't".
The financials improved through out the year too, and judging from the last PR's the profits will increase in 2014. the future is getting better for CBMX